Nomura Holdings’s GSK GSK Stock Holding History

Nomura Holdings’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Buy	+22,500	New	+$1.19M	﹤0.01%	1305
2022 Q3	–	Sell	-480,000	Closed	-$26.3M	–	1806
2022 Q2	$26.3M	Hold	480,000	–	–	0.09%	138
2022 Q1	$26.2M	Buy	+480,000	New	+$26.1M	0.08%	153
2021 Q3	–	Sell	-320,000	Closed	-$16M	–	2077
2021 Q2	$16M	Buy	+320,000	New	+$15.4M	0.04%	253
2015 Q1	–	Sell	-160,000	Closed	-$8.54M	–	1974
2014 Q4	$8.54M	Hold	160,000	–	–	0.02%	412
2014 Q3	$9.21M	Buy	+160,000	New	+$9.81M	0.03%	463

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nomura Holdings's GSK Position: Q2 2026 in Review

Nomura Holdings opened a new position in GSK (GSK) in Q2 2026: 6,706 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #1578 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in GSK as recently as Q2 2024.

Nomura Holdings first reported a position in GSK in Q2 2013 and has held it in 27 quarters since. The position peaked at $193M in Q4 2021. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Nomura Holdings held 6,706 shares of GSK worth $352K as of Q2 2026.
GSK was a new Nomura Holdings position in Q2 2026.
GSK made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1578 holding.
Nomura Holdings first reported a position in GSK in Q2 2013 and has held it in 27 quarters since.
Nomura Holdings's GSK position peaked at $193M in Q4 2021.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.